Identifying the susceptibility genes for coronary artery disease: From hyperbole through doubt to cautious optimism

Journal of Internal Medicine

Volumn 263, Issue 5, 2008, Pages 538-552

  Hamsten, A ^a   Eriksson, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Coronary artery disease; Gene polymorphism; Genome wide association

Indexed keywords

ATHEROSCLEROSIS; CHROMOSOME 9P; CONFERENCE PAPER; CORONARY ARTERY DISEASE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

ANIMALS; ATHEROSCLEROSIS; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MICE; MOLECULAR BIOLOGY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 42149106981     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01958.x     Document Type: Conference Paper

References (141)

1. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001 27 : 234 6.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 : 1685 95.
3. Collins FC. Medical and societal consequences of the human genome project. N Engl J Med 1999 341 : 28 37.
4. Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet 2006 3 : 163 73.
5. McPherson R, Pertsemlidis A, Kavaslar N et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007 316 : 1488 91.
6. Helgadottir A, Thorleifsson G, Manolescu A et al. A common variant on chromosome 9p21 affects risk of myocardial infarction. Science 2007 316 : 1491 3.
7. Samani NJ, Erdmann J, Hall AS et al. Genome-wide association analysis of coronary artery disease. N Engl J Med 2007 357 : 443 53.
8. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 : 661 78.
9. Herbert A, Gerry NP, McQueen MB et al. A Common genetic variant is associated with adult and childhood obesity. Science 2006 312 : 279 83.
10. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006 38 : 320 3.
11. Zeggini E, Weedon MN, Lindgren CM et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007 316 : 1336 41.
12. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007 316 : 1341 5.
13. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of Biomedical Research et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007 316 : 1331 6.
14. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994 330 : 1041 6.
15. Lloyd-Jones D, Nam DH, D'Agostino Sr. RB et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004 291 : 2204 11.
16. Motulsky AG, Brunzell JD. Genetics of coronary artery disease. In : King RA, Rotter JI, Motulsky AG, eds. The Genetic Basis of Common Disease, 2nd edn. New York, NY : Oxford University Press, 2002 105 25.
17. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, de Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20966 Swedish twins. J Intern Med 2002 252 : 247 54.
18. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 364 : 937 52.
19. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004 160 : 421 9.
20. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001 17 : 502 10.
21. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies support a contribution of common variants to susceptibility to common diseases. Nat Genet 2003 33 : 177 82.
22. Smith DJ, Lusis AJ. The allelic structure of common disease. Hum Mol Genet 2002 11 : 2455 61.
23. Wang WYS, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005 6 : 109 18.
24. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001 29 : 306 9.
25. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003 361 : 567 71.
26. Hamsten A. Molecular genetics as the route to understanding, prevention and treatment. Lancet 1996 348 : S17 9.
27. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996 273 : 1516 7.
28. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001 2 : 91 9.
29. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 2005 366 : 1223 34.
30. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004 5 : 89 100.
31. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005 366 : 1315 23.
32. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004 96 : 434 42.
33. Thomas D, Clayton D. Betting odds and genetic associations. J Natl Cancer Inst 2004 96 : 421 3.
34. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003 100 : 9440 5.
35. Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden death. Circulation 1996 93 : 1354 63.
36. Stengard JH, Kardia SL, Tervahauta M, Ehnholm C, Nissinen A, Sing CF. Utility of predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65-84 years is dependent on context defined by Apo E genotype and area of residence. Clin Genet 1999 56 : 367 77.
37. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001 358 : 115 9.
38. Hines LM, Stampfer MJ, Ma J et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001 344 : 549 55.
39. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004 431 : 931 45.
40. International HapMap Consortium. A haplotype map of the human genome. Nature 2005 437 : 1299 320.
41. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007 449 : 851 61.
42. Gibbs RA, Belmont JW, Hardenbol P et al. The international HapMap project. Nature 2003 426 : 789 96.
43. Altshuler D et al. A haplotype map of the human genome. Nature 2005 437 : 1299 320.
44. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001 29 : 229 32.
45. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002 296 : 2225 9.
46. Matsuzaki H, Loi H, Dong S et al. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 2004 14 : 414 25.
47. Hinds DA, Stuve LL, Nilsen GB et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005 307 : 1072 9.
48. Gundersen KL, Steemers FJ, Lee G, Mendoza LD, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 2005 37 : 549 54.
49. Steemers FJ, Chang W, Lee G, Barker DL, Shen R, Gundersen KL. Whole-genome genotyping with the single-base extension assay. Nat Methods 2006 3 : 31 3.
50. Iafrate AJ, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat Genet 2004 36 : 949 51.
51. Sebat J, Lakshmi B, Troge J et al. Large-scale copy number polymorphism in the human genome. Science 2004 305 : 525 8.
52. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 2006 444 : 444 54.
53. Estivil X, Armengol L. Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007 3 : 1787 99.
54. Stranger BE, Forrest MS, Dunning M et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007 315 : 848 53.
55. Lusis AJ, Fogelman AM, Fornarow GC. Genetic basis of atherosclerosis. Part I. New genes and pathways. Circulation 2004 110 : 1868 73.
56. Lusis AJ, Fogelman AM, Fornarow GC. Genetic basis of atherosclerosis. Part II. Clinical implications. Circulation 2004 110 : 2066 71.
57. Arnett DK, Baird AE, Barkley RA et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease. A scientific statement from the American Heart Association council on epidemiology and prevention, the Stroke council, and the functional genomics and translational biology interdisciplinary working group. Circulation 2007 115 : 2878 901.
58. Topol EJ, McCarthy J, Gabriel S et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial myocardial infarction. Circulation 2001 104 : 2641 4.
59. Yamada Y, Izawa H, Ichihara S et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002 347 : 1916 23.
60. Lander ES, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995 11 : 241 7.
61. Pollex RL, Hegele RA. Complex trait locus linkage mapping in atherosclerosis: time to take a step back before moving forward? Arterioscler Thromb Vasc Biol 2005 25 : 1541 4.
62. Helgadottir A, Thorleifsson G, Manolescu A et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004 36 : 233 9.
63. Pajukanta P, Cargill M, Viitanen L et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000 67 : 1481 93.
64. Francke S, Manraj M, Lacquemant C et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians, a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001 10 : 2751 65.
65. Broeckel U, Hengstenberg C, Mayer B et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002 30 : 210 4.
66. Harrap SB, Zammit KS, ZYH Wong et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 2002 22 : 874 8.
67. Wang Q, Rao S, Shen G-Q et al. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genome-wide linkage analysis. Am J Hum Genet 2004 74 : 262 71.
68. Hauser ER, Crossman DC, Granger CB et al. A genome-wide scan for early-onset coronary artery disease in 438 families: the GENECARD study. Am J Hum Genet 2004 75 : 436 47.
69. Samani NJ, Burton P, Mangino M et al. A genome-wide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet 2005 77 : 1011 20.
70. Farrall M, Green FR, Peden J et al. Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet 2006 2 : e72.
71. Eberle MA, Ng PC, Kuhn K et al. Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genet 2007 3 : 1827 37.
72. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006 38 : 209 13.
73. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005 37 : 413 7.
74. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-a gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002 32 : 650 4.
75. Sladek R, Rochelau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007 445 : 881 5.
76. Salonen JT, Uimari P, Aalto JM et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 2007 81 : 338 45.
77. Broadbent HM, Peden JF, Lorkowski S et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked, SNPs in the ANRIL locus on chromosome 9. Hum Mol Genet 2008 17 : 806 14.
78. Pasmant E, Lauremdeau L, Heron D, Vidaud M, Vidaud D, Bieche I. Characterisation of germ-line deletion, including the entire INK4/ARF locus in a melanoma-neural system tumor family: identification of ANRIL, an antisense non-coding RNA whose expression co-clusters with ARF. Cancer Res 2007 67 : 3963 9.
79. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006 15 (spec no 1 R17 9.
80. Helgadottir A, Thorleifsson G, Magnusson KP et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008 40 : 217 24.
81. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005 85 : 1 31.
82. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004 110 : 16 21.
83. Mouse Genome Sequencing Consortium. Initial sequencing and comparative analysis of the mouse genome. Nature 2002 420 : 520 62.
84. Allayee H, Ghazalpour A, Lusis AJ. Using mice to dissect genetic factors in atherosclerosis. Arterioscler Thromb Vasc Biol 2003 23 : 1501 9.
85. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 2007 8 : 58 69.
86. Pennacchio LA. Insights from human/mouse genome comparisons. Mamm Genome 2003 14 : 429 36.
87. Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative studies. Am J Hum Genet 2005 77 : 1 15.
88. Wang X, Paigen B. Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans. Curr Opin Lipidol 2005 16 : 127 37.
89. Wang X, Ria M, Kelmenson PM et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 2005 37 : 365 72.
90. Swanberg M, Lidman O, Padyokov L et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to multiple sclerosis, rheumatoid arthritis and myocardial infarction. Nat Genet 2005 37 : 486 94.
91. Mehrabian M, Allayee H, Wong J et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002 91 : 120 6.
92. Dwyer JH, Allayee H, Dwyer KM et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004 350 : 29 37.
93. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 : 508 19.
94. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 2004 90 : 983 8.
95. Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002 47 : 185 92.
96. Ameziane N, Beillat T, Verpillat P et al. Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003 23 : e61 4.
97. Edfeldt K, Bennet AM, Eriksson P et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004 25 : 1447 53.
98. Helgadottir A, Manolescu A, Helgason A et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006 38 : 68 74.
99. Ozaki K, Inoue K, Sato H et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 2004 429 : 72 5.
100. Weinberg AD. OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines. Trends Immunol 2002 23 : 102 9.
101. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 : 1461 3.
102. Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007 80 : 273 90.
103. Wallberg-Jonsson S, Öhman ML, Rantapää-Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997 24 : 445 51.
104. Sing CF, Stengård JH, Kardia SLR. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003 23 : 1190 6.
105. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 2006 38 : 218 22.
106. Schadt EE, Lamb J, Yang X et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005 37 : 710 7.
107. Morley M, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F. Genetic analysis of genome-wide variation in human gene expression. Nature 2004 12 : 430.
108. Pastinen T, Hudson TJ. Cis-acting regulatory variation in the human genome. Science 2004 306 : 647 50.
109. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet 2003 33 : 228 37.
110. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science 2002 297 : 1143.
111. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 2003 33 : 469 75.
112. Zhu C, Odeberg J, Hamsten A, Eriksson P. Allele-specific MMP-3 transciption under in vivo conditions. Biochem Biophys Res Commun 2006 348 : 1150 6.
113. Eriksson P, Kallin B, Van't Hooft F, Båvenholm P, Hamsten A. Allele-specific increase in basal PAI-1 transcription associated with myocardial infarction. Proc Natl Acad Sci USA 1995 92 : 1851 5.
114. Eriksson P, Nilsson L, Karpe F, Hamsten A. Very low density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridaemia. Arterioscler Thromb Vasc Biol 1998 18 : 20 6.
115. van't Hooft F, Silveira A, Tornvall P, Iliadou A, Eriksson P, Hamsten A. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene influencing plasma factor VII activity and mass concentration. Blood 1999 93 : 3432 41.
116. van't Hooft F, Jormsjö S, Tornvall P, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the apolipoprotein B gene influencing the plasma low density lipoprotein level and the risk of myocardial infarction in middle-aged men. J Lipid Res 1999 40 : 1686 94.
117. van't Hooft F, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 2001 104 : 1223 8.
118. Ye S, Eriksson P, Hamsten A, Humphries SE, Kurkinen M, Henney AM. Functional analysis of a common genetic variant in the human stromelysin-1 gene promoter. J Biol Chem 1996 271 : 13055 60.
119. Zhang B, Shu Y, Herrmann S-M et al. A functional polymorphism in the regulatory region of the gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999 99 : 1788 94.
120. Jormsjö S, Ye S, Moritz J et al. Differential regulation of matrix metalloelastase (MMP-12) gene activity influences coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res 2000 86 : 998 1003.
121. Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 2001 276 : 7549 58.
122. Eriksson P, Deguchi H, Samnegård A et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 2004 24 : 551 7.
123. Skoog T, Van't Hooft FM, Eriksson P et al. A common functional polymorphism (G to A substitution at position -863) in the promoter region of the tumor necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999 8 : 1443 9. 351 : 777 83.
124. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004 431 : 371 8.
125. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell 2005 122 : 9 12.
126. Seo D, Wang T, Dressman H et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004 24 : 1922 7.
127. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004 305 : 869 72.
128. Cohen JC, Boerwinkle E, Mosley Jr. TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006 354 : 1264 72.
129. Romeo S, Pennacchio LA, Fu Y, Tybjaerg-Hansen A, Hobbs HH, Cohen JC. Population-based resequencing of ANPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007 39 : 513 6.
130. Service RF. Gene sequencing: the race for the $1000 genome. Science 2006 311 : 1544 6.
131. Chi KR. The year of sequencing. Nat Methods 2008 5 : 11 4.
132. Rusk N, Kiermer V. Primer: sequencing - the next generation. Nat Methods 2008 5 : 15.
133. Humphries SE, Ridker PM, Talmud PJ. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation? Arterioscler Thromb Vasc Biol 2004 24 : 628 36.
134. Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics 2005 6 : 639 46.
135. Collins FC. The case for a US prospective cohort study of genes and environment. Nature 2004 429 : 475 7.
136. Burton PR, Hansell A. UK Biobank: The Expected Distribution of Incident and Prevalent Cases of Chronic Disease and the Statistical Power of Nested Case-Control Studies. Manchester, UK : UK Biobank Technical Reports, 2005.
137. Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements. Variations and practical utility. JAMA 1992 267 : 1652 60.
138. Wang SS, Schadt EE, Wang H et al. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 2007 101 : e11 30.
139. Dixon AL, Liang L, Moffatt MF et al. A genome-wide association study of global gene expression. Nat Genet 2007 39 : 1202 7.
140. Göring HHH, Curran JE, Johnson MP et al. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 2007 39 : 1208 16.
141. Stranger BE, Nica AC, Forrest MS et al. Population genomics of human gene expression. Nat Genet 2007 39 : 1217 24.